Redsenol

Canada Royal Enoch Phytomedicine (CREP), widely recognized by its flagship brand Redsenol, is a biopharmaceutical company headquartered in Vancouver, Canada, specializing in the research and production of rare ginsenosides. The company focuses on the development of high-purity multicomponent ginsenoside formulations, such as Redsenol-1 and Redsenol-DAG, which are designed to provide supportive care for cancer patients and enhance overall immune function. Utilizing proprietary extraction and transformation technologies, CREP converts common ginsenosides into highly bioactive rare forms like Rg3, Rh2, Rk1, and Rg5. The company's products are marketed globally, bridging traditional herbal medicine with modern evidence-based phytotherapy to address unmet needs in oncology support and chronic disease management.